| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peptidyltransferase activity | 2.43e-07 | 6 | 47 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 2.43e-07 | 6 | 47 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 6.79e-07 | 8 | 47 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 1.02e-06 | 9 | 47 | 3 | GO:0036374 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 6.70e-06 | 16 | 47 | 3 | GO:0008242 | |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 1.35e-05 | 20 | 47 | 3 | GO:0070003 | |
| GeneOntologyMolecularFunction | chromo shadow domain binding | 8.09e-05 | 6 | 47 | 2 | GO:0070087 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 4.68e-04 | 599 | 47 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | neurexin family protein binding | 6.37e-04 | 16 | 47 | 2 | GO:0042043 | |
| GeneOntologyMolecularFunction | chloride ion binding | 6.37e-04 | 16 | 47 | 2 | GO:0031404 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 9.89e-04 | 188 | 47 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 1.00e-03 | 20 | 47 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 2.11e-03 | 29 | 47 | 2 | GO:0005540 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 5.77e-07 | 8 | 46 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | peptide modification | 1.23e-06 | 10 | 46 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 1.23e-06 | 10 | 46 | 3 | GO:1901750 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 1.69e-06 | 11 | 46 | 3 | GO:0006751 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 2.25e-06 | 12 | 46 | 3 | GO:1901748 | |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 5.70e-06 | 16 | 46 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 1.15e-05 | 20 | 46 | 3 | GO:0006750 | |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 1.34e-05 | 21 | 46 | 3 | GO:0000097 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 1.46e-05 | 3 | 46 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | leukotriene biosynthetic process | 1.55e-05 | 22 | 46 | 3 | GO:0019370 | |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 1.55e-05 | 22 | 46 | 3 | GO:0019184 | |
| GeneOntologyBiologicalProcess | serine family amino acid biosynthetic process | 2.31e-05 | 25 | 46 | 3 | GO:0009070 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 2.91e-05 | 4 | 46 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | peptide metabolic process | 3.67e-05 | 84 | 46 | 4 | GO:0006518 | |
| GeneOntologyBiologicalProcess | peptide biosynthetic process | 5.92e-05 | 34 | 46 | 3 | GO:0043043 | |
| GeneOntologyBiologicalProcess | modified amino acid catabolic process | 7.65e-05 | 37 | 46 | 3 | GO:0042219 | |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 9.68e-05 | 40 | 46 | 3 | GO:0000096 | |
| GeneOntologyBiologicalProcess | courtship behavior | 1.01e-04 | 7 | 46 | 2 | GO:0007619 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 1.04e-04 | 41 | 46 | 3 | GO:0006691 | |
| GeneOntologyBiologicalProcess | serine family amino acid metabolic process | 1.20e-04 | 43 | 46 | 3 | GO:0009069 | |
| GeneOntologyBiologicalProcess | brainstem development | 1.35e-04 | 8 | 46 | 2 | GO:0003360 | |
| GeneOntologyBiologicalProcess | fatty acid derivative biosynthetic process | 2.13e-04 | 52 | 46 | 3 | GO:1901570 | |
| GeneOntologyBiologicalProcess | modified amino acid biosynthetic process | 2.13e-04 | 52 | 46 | 3 | GO:0042398 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 2.16e-04 | 10 | 46 | 2 | GO:0097105 | |
| GeneOntologyBiologicalProcess | sulfur compound catabolic process | 2.25e-04 | 53 | 46 | 3 | GO:0044273 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 2.47e-04 | 569 | 46 | 7 | GO:0034329 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 2.64e-04 | 11 | 46 | 2 | GO:0097104 | |
| GeneOntologyBiologicalProcess | aggressive behavior | 3.74e-04 | 13 | 46 | 2 | GO:0002118 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 3.74e-04 | 13 | 46 | 2 | GO:0097090 | |
| GeneOntologyBiologicalProcess | glutathione metabolic process | 3.75e-04 | 63 | 46 | 3 | GO:0006749 | |
| GeneOntologyBiologicalProcess | protein processing | 4.19e-04 | 285 | 46 | 5 | GO:0016485 | |
| GeneOntologyBiologicalProcess | icosanoid biosynthetic process | 4.50e-04 | 67 | 46 | 3 | GO:0046456 | |
| GeneOntologyBiologicalProcess | fat cell differentiation | 4.61e-04 | 291 | 46 | 5 | GO:0045444 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid biosynthetic process | 4.91e-04 | 69 | 46 | 3 | GO:0170038 | |
| GeneOntologyBiologicalProcess | male mating behavior | 5.02e-04 | 15 | 46 | 2 | GO:0060179 | |
| GeneOntologyBiologicalProcess | L-amino acid biosynthetic process | 5.12e-04 | 70 | 46 | 3 | GO:0170034 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 5.72e-04 | 16 | 46 | 2 | GO:0007158 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 6.09e-04 | 870 | 46 | 8 | GO:0030855 | |
| GeneOntologyBiologicalProcess | alpha-amino acid biosynthetic process | 6.77e-04 | 77 | 46 | 3 | GO:1901607 | |
| GeneOntologyBiologicalProcess | fatty acid derivative metabolic process | 8.13e-04 | 82 | 46 | 3 | GO:1901568 | |
| GeneOntologyBiologicalProcess | anatomical structure homeostasis | 8.59e-04 | 334 | 46 | 5 | GO:0060249 | |
| GeneOntologyBiologicalProcess | tissue homeostasis | 8.59e-04 | 334 | 46 | 5 | GO:0001894 | |
| GeneOntologyBiologicalProcess | amino acid biosynthetic process | 9.33e-04 | 86 | 46 | 3 | GO:0008652 | |
| GeneOntologyBiologicalProcess | adult behavior | 1.08e-03 | 203 | 46 | 4 | GO:0030534 | |
| GeneOntologyBiologicalProcess | epithelium development | 1.25e-03 | 1469 | 46 | 10 | GO:0060429 | |
| GeneOntologyBiologicalProcess | cell junction organization | 1.27e-03 | 974 | 46 | 8 | GO:0034330 | |
| GeneOntologyBiologicalProcess | maintenance of gastrointestinal epithelium | 1.30e-03 | 24 | 46 | 2 | GO:0030277 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 1.30e-03 | 24 | 46 | 2 | GO:0071625 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle tissue development | 1.41e-03 | 25 | 46 | 2 | GO:0016202 | |
| GeneOntologyBiologicalProcess | growth | 1.42e-03 | 1235 | 46 | 9 | GO:0040007 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 2.12e-03 | 410 | 46 | 5 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of muscle organ development | 2.17e-03 | 31 | 46 | 2 | GO:0048634 | |
| GeneOntologyBiologicalProcess | negative regulation of miRNA transcription | 2.17e-03 | 31 | 46 | 2 | GO:1902894 | |
| GeneOntologyBiologicalProcess | adult locomotory behavior | 2.21e-03 | 116 | 46 | 3 | GO:0008344 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 2.96e-05 | 4 | 47 | 2 | GO:0098983 | |
| GeneOntologyCellularComponent | inhibitory synapse | 4.58e-05 | 31 | 47 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | interphotoreceptor matrix | 7.38e-05 | 6 | 47 | 2 | GO:0033165 | |
| GeneOntologyCellularComponent | symmetric synapse | 3.80e-04 | 13 | 47 | 2 | GO:0032280 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 5.01e-04 | 164 | 47 | 4 | GO:0098982 | |
| GeneOntologyCellularComponent | glycinergic synapse | 9.16e-04 | 20 | 47 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.15e-03 | 530 | 47 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 1.32e-03 | 24 | 47 | 2 | GO:0098985 | |
| MousePheno | abnormal circulating glutathione level | 1.70e-07 | 5 | 37 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 1.70e-07 | 5 | 37 | 3 | MP:0030653 | |
| MousePheno | increased glutathione level | 1.70e-07 | 5 | 37 | 3 | MP:0012606 | |
| MousePheno | glutathionuria | 1.70e-07 | 5 | 37 | 3 | MP:0013730 | |
| MousePheno | abnormal long bone hypertrophic chondrocyte zone | 4.63e-07 | 113 | 37 | 6 | MP:0000165 | |
| MousePheno | decreased circulating cysteine level | 5.93e-07 | 7 | 37 | 3 | MP:0030626 | |
| MousePheno | abnormal bone structure | CDH23 NCOR2 PAPPA FLNB THBS2 AFAP1L2 WDR1 NDUFA10 CLSTN1 ADAM8 GGT2P GGT1 GGT3P SMAD3 BRD9 | 8.69e-07 | 1379 | 37 | 15 | MP:0003795 |
| MousePheno | abnormal long bone epiphyseal plate proliferative zone | 9.06e-07 | 68 | 37 | 5 | MP:0003662 | |
| MousePheno | epididymis hypoplasia | 9.47e-07 | 8 | 37 | 3 | MP:0004932 | |
| MousePheno | decreased cysteine level | 9.47e-07 | 8 | 37 | 3 | MP:0030623 | |
| MousePheno | abnormal limb morphology | NUBP1 PAPPA FLNB UXS1 SYNM SCARF2 GGT2P VCAN GGT1 GGT3P SMAD3 CREB3L2 CAST | 1.15e-06 | 1028 | 37 | 13 | MP:0002109 |
| MousePheno | nervous | 1.42e-06 | 9 | 37 | 3 | MP:0008912 | |
| MousePheno | increased osteoclast cell number | 1.69e-06 | 77 | 37 | 5 | MP:0004984 | |
| MousePheno | limbs/digits/tail phenotype | NUBP1 PAPPA FLNB THBS2 UXS1 SYNM SCARF2 GGT2P VCAN GGT1 GGT3P SMAD3 CREB3L2 CAST | 1.79e-06 | 1258 | 37 | 14 | MP:0005371 |
| MousePheno | kyphosis | 1.96e-06 | 229 | 37 | 7 | MP:0000160 | |
| MousePheno | failure of copulatory plug deposition | 2.02e-06 | 10 | 37 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 2.02e-06 | 10 | 37 | 3 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 2.02e-06 | 10 | 37 | 3 | MP:0005158 | |
| MousePheno | abnormal circulating cysteine level | 2.78e-06 | 11 | 37 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 2.78e-06 | 11 | 37 | 3 | MP:0011130 | |
| MousePheno | decreased circulating estradiol level | 2.87e-06 | 38 | 37 | 4 | MP:0005181 | |
| MousePheno | decreased tertiary ovarian follicle number | 3.20e-06 | 39 | 37 | 4 | MP:0011129 | |
| MousePheno | decreased circulating estrogen level | 3.92e-06 | 41 | 37 | 4 | MP:0003371 | |
| MousePheno | abnormal cysteine level | 4.79e-06 | 13 | 37 | 3 | MP:0030621 | |
| MousePheno | decreased glutathione level | 4.79e-06 | 13 | 37 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 4.79e-06 | 13 | 37 | 3 | MP:0012603 | |
| MousePheno | abnormal tibia morphology | 4.86e-06 | 375 | 37 | 8 | MP:0000558 | |
| MousePheno | decreased long bone epiphyseal plate size | 5.23e-06 | 44 | 37 | 4 | MP:0006396 | |
| MousePheno | abnormal cartilage development | 5.39e-06 | 172 | 37 | 6 | MP:0000164 | |
| MousePheno | abnormal long bone epiphyseal plate morphology | 5.39e-06 | 172 | 37 | 6 | MP:0003055 | |
| MousePheno | abnormal hindlimb zeugopod morphology | 5.47e-06 | 381 | 37 | 8 | MP:0003857 | |
| MousePheno | priapism | 6.09e-06 | 14 | 37 | 3 | MP:0003415 | |
| MousePheno | abnormal tertiary ovarian follicle number | 6.83e-06 | 47 | 37 | 4 | MP:0011127 | |
| MousePheno | abnormal long bone morphology | 6.95e-06 | 676 | 37 | 10 | MP:0003723 | |
| MousePheno | abnormal osteoclast morphology | 7.69e-06 | 183 | 37 | 6 | MP:0004982 | |
| MousePheno | abnormal epiphyseal plate morphology | 8.19e-06 | 185 | 37 | 6 | MP:0006395 | |
| MousePheno | abnormal copulatory plug deposition | 9.34e-06 | 16 | 37 | 3 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 9.34e-06 | 16 | 37 | 3 | MP:0008477 | |
| MousePheno | abnormal circulating estradiol level | 1.03e-05 | 52 | 37 | 4 | MP:0005183 | |
| MousePheno | failure of superovulation | 1.36e-05 | 18 | 37 | 3 | MP:0031422 | |
| MousePheno | abnormal penile erection | 1.36e-05 | 18 | 37 | 3 | MP:0001379 | |
| MousePheno | oocyte degeneration | 1.36e-05 | 18 | 37 | 3 | MP:0009093 | |
| MousePheno | abnormal circulating estrogen level | 1.48e-05 | 57 | 37 | 4 | MP:0003369 | |
| MousePheno | abnormal tertiary ovarian follicle morphology | 1.48e-05 | 57 | 37 | 4 | MP:0009363 | |
| MousePheno | abnormal copulation physiology | 1.61e-05 | 19 | 37 | 3 | MP:0031627 | |
| MousePheno | increased circulating growth hormone level | 1.61e-05 | 19 | 37 | 3 | MP:0005123 | |
| MousePheno | abnormal limb bone morphology | 1.65e-05 | 587 | 37 | 9 | MP:0002115 | |
| MousePheno | abnormal spine curvature | 1.69e-05 | 318 | 37 | 7 | MP:0004174 | |
| MousePheno | impaired ovarian folliculogenesis | 1.95e-05 | 61 | 37 | 4 | MP:0001129 | |
| MousePheno | abnormal osteoclast cell number | 2.05e-05 | 128 | 37 | 5 | MP:0004983 | |
| MousePheno | small vertebrae | 2.54e-05 | 22 | 37 | 3 | MP:0004610 | |
| MousePheno | abnormal superovulation | 2.66e-05 | 66 | 37 | 4 | MP:0009648 | |
| MousePheno | increased growth hormone level | 2.91e-05 | 23 | 37 | 3 | MP:0005137 | |
| MousePheno | uterus hypoplasia | 2.91e-05 | 23 | 37 | 3 | MP:0001121 | |
| MousePheno | abnormal copulation behavior | 3.33e-05 | 24 | 37 | 3 | MP:0009697 | |
| MousePheno | nuclear cataract | 4.26e-05 | 26 | 37 | 3 | MP:0010254 | |
| MousePheno | kyphoscoliosis | 4.78e-05 | 27 | 37 | 3 | MP:0000069 | |
| MousePheno | abnormal phagocyte morphology | NCOR2 FLNB AFAP1L2 WDR1 ADAM8 GGT2P GGT1 GGT3P SMAD3 IMPG2 BRD9 | 4.86e-05 | 1033 | 37 | 11 | MP:0008251 |
| MousePheno | hindlimb paralysis | 5.42e-05 | 79 | 37 | 4 | MP:0000755 | |
| MousePheno | enhanced wound healing | 5.95e-05 | 29 | 37 | 3 | MP:0002724 | |
| MousePheno | aminoaciduria | 5.95e-05 | 29 | 37 | 3 | MP:0003311 | |
| MousePheno | increased macrophage cell number | 6.35e-05 | 162 | 37 | 5 | MP:0005425 | |
| MousePheno | limb paralysis | 6.57e-05 | 83 | 37 | 4 | MP:0013147 | |
| MousePheno | short tibia | 7.49e-05 | 274 | 37 | 6 | MP:0002764 | |
| MousePheno | abnormal myeloid leukocyte morphology | NCOR2 FLNB AFAP1L2 WDR1 CLSTN1 ADAM8 GGT2P GGT1 GGT3P SMAD3 IMPG2 BRD9 | 7.65e-05 | 1292 | 37 | 12 | MP:0008250 |
| MousePheno | abnormal appendicular skeleton morphology | 7.91e-05 | 896 | 37 | 10 | MP:0009250 | |
| MousePheno | decreased length of long bones | 8.40e-05 | 409 | 37 | 7 | MP:0004686 | |
| MousePheno | anovulation | 8.82e-05 | 33 | 37 | 3 | MP:0008869 | |
| MousePheno | abnormal limb long bone morphology | 9.61e-05 | 568 | 37 | 8 | MP:0011504 | |
| MousePheno | decreased circulating follicle stimulating hormone level | 9.65e-05 | 34 | 37 | 3 | MP:0002790 | |
| MousePheno | small uterus | 9.83e-05 | 92 | 37 | 4 | MP:0002637 | |
| MousePheno | abnormal hindlimb morphology | 1.06e-04 | 576 | 37 | 8 | MP:0000556 | |
| MousePheno | abnormal ovulation | 1.21e-04 | 97 | 37 | 4 | MP:0001928 | |
| MousePheno | abnormal reproductive system development | 1.31e-04 | 99 | 37 | 4 | MP:0003936 | |
| MousePheno | abnormal skeleton development | 1.46e-04 | 447 | 37 | 7 | MP:0002113 | |
| MousePheno | abnormal macrophage morphology | 1.82e-04 | 463 | 37 | 7 | MP:0002446 | |
| MousePheno | induced hyperactivity | 1.83e-04 | 42 | 37 | 3 | MP:0008911 | |
| MousePheno | decreased follicle stimulating hormone level | 2.10e-04 | 44 | 37 | 3 | MP:0005130 | |
| MousePheno | absent estrous cycle | 2.10e-04 | 44 | 37 | 3 | MP:0009009 | |
| MousePheno | abnormal cartilage morphology | 2.28e-04 | 336 | 37 | 6 | MP:0000163 | |
| MousePheno | paralysis | 2.65e-04 | 119 | 37 | 4 | MP:0000753 | |
| MousePheno | abnormal ovarian folliculogenesis | 2.74e-04 | 120 | 37 | 4 | MP:0001130 | |
| MousePheno | cataract | 2.80e-04 | 497 | 37 | 7 | MP:0001304 | |
| MousePheno | decreased thyroxine level | 3.26e-04 | 51 | 37 | 3 | MP:0005471 | |
| MousePheno | short femur | 3.40e-04 | 127 | 37 | 4 | MP:0003109 | |
| MousePheno | abnormal gait | 3.69e-04 | 520 | 37 | 7 | MP:0001406 | |
| MousePheno | decreased femur size | 3.72e-04 | 130 | 37 | 4 | MP:0030825 | |
| MousePheno | aciduria | 4.07e-04 | 55 | 37 | 3 | MP:0010028 | |
| MousePheno | abnormal mononuclear phagocyte morphology | 4.22e-04 | 705 | 37 | 8 | MP:0008248 | |
| MousePheno | disproportionate dwarf | 4.53e-04 | 57 | 37 | 3 | MP:0002427 | |
| MousePheno | abnormal growth hormone level | 4.53e-04 | 57 | 37 | 3 | MP:0003968 | |
| MousePheno | abnormal urine amino acid level | 5.01e-04 | 59 | 37 | 3 | MP:0011468 | |
| MousePheno | immotile sperm | 5.01e-04 | 59 | 37 | 3 | MP:0020869 | |
| MousePheno | decreased circulating gonadotropin level | 5.26e-04 | 60 | 37 | 3 | MP:0003363 | |
| MousePheno | decreased circulating testosterone level | 5.26e-04 | 60 | 37 | 3 | MP:0002780 | |
| MousePheno | decreased circulating insulin-like growth factor I level | 5.53e-04 | 61 | 37 | 3 | MP:0004701 | |
| MousePheno | diluted coat color | 6.36e-04 | 64 | 37 | 3 | MP:0000371 | |
| MousePheno | scoliosis | 6.36e-04 | 64 | 37 | 3 | MP:0000161 | |
| MousePheno | abnormal thyroxine level | 6.96e-04 | 66 | 37 | 3 | MP:0005469 | |
| MousePheno | absent corpus luteum | 6.96e-04 | 66 | 37 | 3 | MP:0001134 | |
| Domain | NLGN4 | 5.42e-06 | 2 | 44 | 2 | IPR030025 | |
| Domain | Nlgn | 5.40e-05 | 5 | 44 | 2 | IPR000460 | |
| Domain | GGT_peptidase | 1.13e-04 | 7 | 44 | 2 | IPR000101 | |
| Domain | G_GLU_TRANSPEPTIDASE | 1.13e-04 | 7 | 44 | 2 | PS00462 | |
| Domain | G_glu_transpept | 1.13e-04 | 7 | 44 | 2 | PF01019 | |
| Domain | EGF_3 | 2.20e-04 | 235 | 44 | 5 | PS50026 | |
| Domain | EGF-like_dom | 2.87e-04 | 249 | 44 | 5 | IPR000742 | |
| Domain | EGF_1 | 3.21e-04 | 255 | 44 | 5 | PS00022 | |
| Domain | EGF-like_CS | 3.57e-04 | 261 | 44 | 5 | IPR013032 | |
| Domain | EGF_2 | 3.83e-04 | 265 | 44 | 5 | PS01186 | |
| Domain | Carboxylesterase_B_CS | 4.16e-04 | 13 | 44 | 2 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 4.85e-04 | 14 | 44 | 2 | PS00941 | |
| Domain | COesterase | 4.85e-04 | 14 | 44 | 2 | PF00135 | |
| Domain | CarbesteraseB | 4.85e-04 | 14 | 44 | 2 | IPR002018 | |
| Domain | - | 1.45e-03 | 95 | 44 | 3 | 2.60.120.200 | |
| Domain | EGF | 2.24e-03 | 235 | 44 | 4 | SM00181 | |
| Domain | VWFC_1 | 3.25e-03 | 36 | 44 | 2 | PS01208 | |
| Domain | BROMODOMAIN_1 | 3.43e-03 | 37 | 44 | 2 | PS00633 | |
| Domain | VWC | 3.61e-03 | 38 | 44 | 2 | SM00214 | |
| Domain | VWFC_2 | 3.61e-03 | 38 | 44 | 2 | PS50184 | |
| Domain | BROMODOMAIN_2 | 4.20e-03 | 41 | 44 | 2 | PS50014 | |
| Domain | BROMO | 4.40e-03 | 42 | 44 | 2 | SM00297 | |
| Domain | Bromodomain | 4.40e-03 | 42 | 44 | 2 | IPR001487 | |
| Domain | - | 4.40e-03 | 42 | 44 | 2 | 1.20.920.10 | |
| Domain | VWF_dom | 4.40e-03 | 42 | 44 | 2 | IPR001007 | |
| Domain | Sushi | 6.67e-03 | 52 | 44 | 2 | PF00084 | |
| Domain | CCP | 7.18e-03 | 54 | 44 | 2 | SM00032 | |
| Domain | SUSHI | 7.71e-03 | 56 | 44 | 2 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 7.97e-03 | 57 | 44 | 2 | IPR000436 | |
| Domain | EGF_extracell | 8.80e-03 | 60 | 44 | 2 | IPR013111 | |
| Domain | EGF_2 | 8.80e-03 | 60 | 44 | 2 | PF07974 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 6.41e-06 | 16 | 33 | 3 | MM14680 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 1.75e-05 | 22 | 33 | 3 | MM15961 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 2.29e-05 | 24 | 33 | 3 | MM17249 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 2.60e-05 | 25 | 33 | 3 | MM14858 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 2.93e-05 | 26 | 33 | 3 | MM15190 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 3.29e-05 | 27 | 33 | 3 | MM15908 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 6.08e-05 | 33 | 33 | 3 | MM15963 | |
| Pathway | WP_GLUTATHIONE_AND_ONECARBON_METABOLISM | 7.27e-05 | 35 | 33 | 3 | MM15815 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 9.32e-05 | 38 | 33 | 3 | MM14600 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.01e-04 | 39 | 33 | 3 | MM15695 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 2.88e-04 | 11 | 33 | 2 | M48099 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 3.83e-04 | 61 | 33 | 3 | MM14861 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 7.94e-04 | 18 | 33 | 2 | M39421 | |
| Pathway | WP_FOCAL_ADHESION | 1.14e-03 | 199 | 33 | 4 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.14e-03 | 199 | 33 | 4 | M7253 | |
| Pathway | WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY | 1.27e-03 | 92 | 33 | 3 | MM15823 | |
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 2.31e-09 | 3 | 47 | 3 | 2573352 | |
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 2.31e-08 | 5 | 47 | 3 | 18063838 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 2.31e-08 | 5 | 47 | 3 | 11095909 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 7641802 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 23615310 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 9627710 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 12453183 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 11003618 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 10392451 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 2891746 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 2.31e-08 | 5 | 47 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 2.31e-08 | 5 | 47 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 2.31e-08 | 5 | 47 | 3 | 11089562 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 2.31e-08 | 5 | 47 | 3 | 12468440 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 2.31e-08 | 5 | 47 | 3 | 12225953 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 7775425 | ||
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 2.31e-08 | 5 | 47 | 3 | 8566783 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 30591459 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 9139708 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 2.31e-08 | 5 | 47 | 3 | 9546365 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 11795900 | ||
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 2.31e-08 | 5 | 47 | 3 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 2.31e-08 | 5 | 47 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 2.31e-08 | 5 | 47 | 3 | 24698228 | |
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 2.31e-08 | 5 | 47 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 2.31e-08 | 5 | 47 | 3 | 19760322 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 10474818 | ||
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 14634009 | ||
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 17363454 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 4.61e-08 | 6 | 47 | 3 | 8101000 | |
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 8663190 | ||
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 4.61e-08 | 6 | 47 | 3 | 8104871 | |
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 11463821 | ||
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 25326709 | ||
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 12163373 | ||
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 22242126 | ||
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 27775020 | ||
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 8.06e-08 | 7 | 47 | 3 | 32284594 | |
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 8.06e-08 | 7 | 47 | 3 | 1968405 | |
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 36685533 | ||
| Pubmed | 2.76e-07 | 10 | 47 | 3 | 23863468 | ||
| Pubmed | 8.33e-07 | 14 | 47 | 3 | 18357469 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 25180444 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 18321991 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 18434543 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 23183221 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24855039 | ||
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 1.79e-06 | 2 | 47 | 2 | 37001827 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 25280803 | ||
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 1.79e-06 | 2 | 47 | 2 | 37080762 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 37904480 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 29106499 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 1.79e-06 | 2 | 47 | 2 | 24104404 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 23682772 | ||
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 1.79e-06 | 2 | 47 | 2 | 32243781 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 22989184 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 35403677 | ||
| Pubmed | Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. | 1.86e-06 | 18 | 47 | 3 | 17097888 | |
| Pubmed | 5.30e-06 | 329 | 47 | 6 | 17474147 | ||
| Pubmed | High-Throughput Sequencing Identifies 3 Novel Susceptibility Genes for Hereditary Melanoma. | 5.36e-06 | 3 | 47 | 2 | 32276436 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 32011705 | ||
| Pubmed | ZNF8 Orchestrates with Smad3 to Promote Lung Metastasis by Recruiting SMYD3 in Breast Cancer. | 5.36e-06 | 3 | 47 | 2 | 39225541 | |
| Pubmed | BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma. | 5.36e-06 | 3 | 47 | 2 | 37739089 | |
| Pubmed | Filamin B represses chondrocyte hypertrophy in a Runx2/Smad3-dependent manner. | 5.36e-06 | 3 | 47 | 2 | 17606870 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 18628683 | ||
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 5.36e-06 | 3 | 47 | 2 | 21282647 | |
| Pubmed | 5.59e-06 | 332 | 47 | 6 | 37433992 | ||
| Pubmed | 6.61e-06 | 27 | 47 | 3 | 18478268 | ||
| Pubmed | Analysis of the human HP1 interactome reveals novel binding partners. | 8.25e-06 | 29 | 47 | 3 | 21888893 | |
| Pubmed | Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. | 8.25e-06 | 29 | 47 | 3 | 22424930 | |
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 1.07e-05 | 4 | 47 | 2 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 1.07e-05 | 4 | 47 | 2 | 22671294 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 20579107 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 10938122 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 16077734 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 17292328 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 19822523 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 12909644 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.64e-05 | 235 | 47 | 5 | 30258100 | |
| Pubmed | Cloning and nucleotide sequence of human gamma-glutamyl transpeptidase. | 1.78e-05 | 5 | 47 | 2 | 2904146 | |
| Pubmed | Expression of multiple gamma-glutamyltransferase genes in man. | 1.78e-05 | 5 | 47 | 2 | 7906515 | |
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 1.78e-05 | 5 | 47 | 2 | 18923512 | |
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 1.78e-05 | 5 | 47 | 2 | 10996085 | |
| Pubmed | COL3A1, CXCL8, VCAN, THBS2, and COL1A2 are correlated with the onset of biliary atresia. | 1.78e-05 | 5 | 47 | 2 | 36930067 | |
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 37865312 | ||
| Pubmed | 1.89e-05 | 38 | 47 | 3 | 27820600 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | FNDC3B NCOR2 FLNB SPCS3 THBS2 UXS1 SEC24C NDUFA10 CLSTN1 TRIM28 | 1.96e-05 | 1451 | 47 | 10 | 30550785 |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 21838267 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 29724786 | ||
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 23969417 | ||
| Pubmed | 2.95e-05 | 44 | 47 | 3 | 16332269 | ||
| Pubmed | A comprehensive analysis of 22q11 gene expression in the developing and adult brain. | 3.15e-05 | 45 | 47 | 3 | 14614146 | |
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 12370310 | ||
| Interaction | GMPR2 interactions | 1.35e-05 | 21 | 45 | 3 | int:GMPR2 | |
| Interaction | GGT2P interactions | 1.46e-05 | 3 | 45 | 2 | int:GGT2P | |
| Cytoband | 22q11.21 | 2.06e-04 | 111 | 47 | 3 | 22q11.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q11 | 8.95e-04 | 419 | 47 | 4 | chr22q11 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 1.17e-06 | 13 | 30 | 3 | 564 | |
| GeneFamily | Cadherin related | 3.56e-04 | 17 | 30 | 2 | 24 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.01e-03 | 57 | 30 | 2 | 1179 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN | 7.61e-06 | 407 | 47 | 7 | M19541 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | ITGA6 CDH23 FNDC3B NCOR2 PAPPA UXS1 AFAP1L2 BCAR1 SYNM VCAN CREB3L2 | 2.58e-06 | 880 | 47 | 11 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.51e-06 | 474 | 47 | 8 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500 | 4.88e-05 | 441 | 47 | 7 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | 1.18e-04 | 884 | 47 | 9 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 5.51e-08 | 194 | 47 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 5.51e-08 | 194 | 47 | 6 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.51e-08 | 194 | 47 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 5.68e-08 | 195 | 47 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 8.20e-07 | 164 | 47 | 5 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 176 | 47 | 5 | 5f9ae5eb45603ed0422a3a993ecdbe2ce05d6e45 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 177 | 47 | 5 | 35d42b07d9c31528bf59199e361bb8a3bfbe3b75 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.65e-06 | 189 | 47 | 5 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 1.65e-06 | 189 | 47 | 5 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.74e-06 | 191 | 47 | 5 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 1.78e-06 | 192 | 47 | 5 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-06 | 192 | 47 | 5 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.78e-06 | 192 | 47 | 5 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 1.83e-06 | 193 | 47 | 5 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.83e-06 | 193 | 47 | 5 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.87e-06 | 194 | 47 | 5 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.87e-06 | 194 | 47 | 5 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.92e-06 | 195 | 47 | 5 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 1.92e-06 | 195 | 47 | 5 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-06 | 196 | 47 | 5 | 9d18381d7aaa063094a5df769a04c73350471525 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-06 | 196 | 47 | 5 | a52cb512c6173be92aa9c4d96e2abbc32f45478d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.97e-06 | 196 | 47 | 5 | afddacc0fb8b9c73dad5333137deb471a6ebdc06 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.97e-06 | 196 | 47 | 5 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.02e-06 | 197 | 47 | 5 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.18e-06 | 200 | 47 | 5 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.18e-06 | 200 | 47 | 5 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | proximal-mesenchymal-Pericyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.18e-06 | 200 | 47 | 5 | 03119a979bc912a98e6fc87addcbc25d8ecf2fb0 | |
| ToppCell | proximal-mesenchymal-Pericyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.18e-06 | 200 | 47 | 5 | a81fde3d40b8efb3be535aeb2a44cfbdeb17bc8b | |
| ToppCell | mild-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.01e-05 | 128 | 47 | 4 | 7a0a7af930e9050d473390fe9827f96fd597f790 | |
| ToppCell | mild-Myeloid-CD14_Monocytes_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.21e-05 | 134 | 47 | 4 | 8ba1f8d0af63bb7a802a002e72fe181b203cb451 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.32e-05 | 158 | 47 | 4 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 164 | 47 | 4 | 1d0d88132baaa3154c3e6e4ef0aff795afab08a2 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 164 | 47 | 4 | bd2e10b015d5e6a338675500ec5d81dc39583b3e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-05 | 167 | 47 | 4 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 2.88e-05 | 167 | 47 | 4 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-05 | 167 | 47 | 4 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-05 | 167 | 47 | 4 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | Control-B_cells-Plasma_cells|Control / group, cell type (main and fine annotations) | 3.46e-05 | 175 | 47 | 4 | fb23858cfce71509cafbe0d9728e678012ff2962 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.54e-05 | 176 | 47 | 4 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-05 | 180 | 47 | 4 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 3.86e-05 | 180 | 47 | 4 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-05 | 180 | 47 | 4 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-05 | 180 | 47 | 4 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.95e-05 | 181 | 47 | 4 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-05 | 183 | 47 | 4 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-1|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.12e-05 | 183 | 47 | 4 | 06e4b05d86a7d643569e19575c2c9aa351d33f29 | |
| ToppCell | COVID-19-B_cells-Plasma_cells|COVID-19 / group, cell type (main and fine annotations) | 4.12e-05 | 183 | 47 | 4 | 130c109f63a5e3c8f83cb96e32f4addf513b6415 | |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.21e-05 | 184 | 47 | 4 | 14a5288d861260f63fbe0cbea3569cf643e7597e | |
| ToppCell | 367C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.21e-05 | 184 | 47 | 4 | fc708a5c8a7b19fab973c72dc4383a7d30f8b59a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.21e-05 | 184 | 47 | 4 | e343dd7777a29048e3f12a939f7f782b8b7b4fea | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.30e-05 | 185 | 47 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B_plasma-Plasma_cells|GI_large-bowel / Manually curated celltypes from each tissue | 4.30e-05 | 185 | 47 | 4 | 2cad994207c4afc9d70f4c2d243ffbbcdbba693e | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B_plasma|GI_large-bowel / Manually curated celltypes from each tissue | 4.30e-05 | 185 | 47 | 4 | 989583c487d8c121e3731faf68f863ba43a582e6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.48e-05 | 187 | 47 | 4 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 4.58e-05 | 188 | 47 | 4 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 4.67e-05 | 189 | 47 | 4 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 4.67e-05 | 189 | 47 | 4 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 4.67e-05 | 189 | 47 | 4 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.67e-05 | 189 | 47 | 4 | e9df7ecd36bee1fedce23bb188c68a94fa60462c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.77e-05 | 190 | 47 | 4 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.77e-05 | 190 | 47 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.77e-05 | 190 | 47 | 4 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-05 | 191 | 47 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 191 | 47 | 4 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 4.87e-05 | 191 | 47 | 4 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 192 | 47 | 4 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 4.97e-05 | 192 | 47 | 4 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 192 | 47 | 4 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-05 | 192 | 47 | 4 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.07e-05 | 193 | 47 | 4 | 549a0b750c860b615aff767ad04c9a9d20f802f0 | |
| ToppCell | (5)_Plasma_IgG|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.07e-05 | 193 | 47 | 4 | a94ebb3bca62970d5d17b0234893918ee6b7b808 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 5.17e-05 | 194 | 47 | 4 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.17e-05 | 194 | 47 | 4 | 2260cd817a6661e5eb6645b0c6786e18fd58371e | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.17e-05 | 194 | 47 | 4 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.17e-05 | 194 | 47 | 4 | 3cffb5c58f6d5bd254f39ee9c41b7e1e4da0ff75 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 195 | 47 | 4 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 5.27e-05 | 195 | 47 | 4 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 195 | 47 | 4 | 223f5f07dc28fa13a09bb589884c58043c7928c7 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 195 | 47 | 4 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 196 | 47 | 4 | f47e551ba484687ba6ce8c29a085106131364042 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 196 | 47 | 4 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.38e-05 | 196 | 47 | 4 | a44a648bf209ce037bfc7b3adfcb220aab60728c | |
| ToppCell | (2)_B_cells-(2)_Plasma_cells|(2)_B_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.38e-05 | 196 | 47 | 4 | cc4f59b885d58e43471e85c51d8e366e68d10846 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 5.49e-05 | 197 | 47 | 4 | 3b1c574b3d119b63967bb1306f0353ecc4c522f3 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 197 | 47 | 4 | 86145bc1e585b4ae136e755cafd6579da2abfa65 | |
| ToppCell | Control-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 5.49e-05 | 197 | 47 | 4 | 64cc5f61c88e9560b0f8f6f3151255dffb5c3d66 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 197 | 47 | 4 | cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.60e-05 | 198 | 47 | 4 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | B_cells-Plasmablasts|B_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.60e-05 | 198 | 47 | 4 | c6cab47885be74a64351f843a741dea6d911bde4 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.60e-05 | 198 | 47 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.60e-05 | 198 | 47 | 4 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.60e-05 | 198 | 47 | 4 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | facs-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.60e-05 | 198 | 47 | 4 | e85ae846e293687fd193f4d565525d8d3bd1faea | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.71e-05 | 199 | 47 | 4 | edba1833ef5c4ca122d7c32f97670314e005f93b | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann-Schwann_nonmyelinating|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-05 | 199 | 47 | 4 | a92718a3f1153b8d2196fd343ed5bc0ebc98cad7 | |
| ToppCell | Transverse-(2)_B_cell-(20)_B_cell_IgA_Plasma|Transverse / shred on region, Cell_type, and subtype | 5.71e-05 | 199 | 47 | 4 | 8caaa08b046f766af298d03961ccac6e4569e2a6 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.71e-05 | 199 | 47 | 4 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-05 | 199 | 47 | 4 | 8dc65662c3ca1db2ba0091332f0658abc0afc5de | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.71e-05 | 199 | 47 | 4 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 5.71e-05 | 199 | 47 | 4 | f89d67e3d8cd48ef5c30a5ad71764f4ebbc8bcb3 | |
| Drug | trypanothione disulfide | 4.24e-07 | 140 | 47 | 6 | CID000115098 | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 1.08e-07 | 7 | 44 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 1.72e-07 | 8 | 44 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | diastolic blood pressure, systolic blood pressure | 5.84e-06 | 670 | 44 | 8 | EFO_0006335, EFO_0006336 | |
| Disease | cortical surface area measurement | 1.38e-04 | 1345 | 44 | 9 | EFO_0010736 | |
| Disease | body fat distribution | 2.34e-04 | 202 | 44 | 4 | EFO_0004341 | |
| Disease | glutamate measurement | 8.60e-04 | 29 | 44 | 2 | EFO_0010487 | |
| Disease | pulse pressure measurement | 9.34e-04 | 1392 | 44 | 8 | EFO_0005763 | |
| Disease | joint hypermobility measurement | 1.11e-03 | 33 | 44 | 2 | EFO_0007905 | |
| Disease | ascending aortic diameter | 1.20e-03 | 140 | 44 | 3 | EFO_0021787 | |
| Disease | cortical thickness | 1.20e-03 | 1113 | 44 | 7 | EFO_0004840 | |
| Disease | hemorrhoid | 1.38e-03 | 147 | 44 | 3 | EFO_0009552 | |
| Disease | hippocampal CA1 volume | 2.35e-03 | 48 | 44 | 2 | EFO_0009394 | |
| Disease | Crohn Disease | 2.54e-03 | 50 | 44 | 2 | C0010346 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.85e-03 | 53 | 44 | 2 | C4707243 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| STSEVYGDPEVHPQS | 201 | Q8NBZ7 | |
| YPETSEHFSGGEPDV | 1486 | P13611 | |
| SVGEQPDVTHDPYEF | 571 | Q9H8M2 | |
| PPEVADGGVVDSGVY | 396 | P56945 | |
| EYGSSVDGHPEVPET | 306 | Q8N4X5 | |
| GTSHEPFSVTEDYPL | 476 | O94985 | |
| TEDGTAYEPVPEGTR | 576 | P78325 | |
| VPHGYLSEDEGVTEE | 636 | Q13111 | |
| SYEASVPEDIPEGHS | 1106 | Q9H251 | |
| DYLIVDTPPGTSDEH | 166 | P53384 | |
| PEFYTPDDGGTAHLS | 371 | A6NGU5 | |
| HGSSYSPEGVEPVSP | 2041 | Q9Y618 | |
| PEDIPHEADVYVSTG | 226 | M0R2J8 | |
| DGTHTVTYTPSQEGP | 1476 | O75369 | |
| VEDTHYPPGASVPTE | 1191 | Q02817 | |
| PYEVGGETEHDESLV | 236 | P23229 | |
| ESEPSPAVTYIHGSG | 931 | Q13219 | |
| FPEAGIHYPDSTTGD | 86 | O95299 | |
| DSAHGDEVPYVFGIP | 486 | Q8NFZ3 | |
| HPAEDTEGTEFEPEG | 2966 | P49454 | |
| TPESPEIVSVEEGGY | 191 | Q9NQL9 | |
| TEPEDVASEVYHGPE | 711 | Q53EP0 | |
| GPEETEEENTTYTGP | 166 | P20810 | |
| SHSPPRYTDQGGEEE | 76 | O75208 | |
| PPEEASPYVVDHGES | 406 | P53992 | |
| DSAHGDEVPYVFGIP | 486 | Q8N0W4 | |
| IYEEHSPPEESSSPG | 431 | Q70SY1 | |
| PEFYTPDDGGTAHLS | 371 | P36268 | |
| SEEHPSSENIPPGYE | 351 | Q96PX1 | |
| GEQSYFVSTPDEHPG | 826 | O15061 | |
| SGHPAYAEVEPVGEK | 506 | Q6UX71 | |
| TGSGHVSVPFPDTYE | 161 | P61009 | |
| YEPEVVAVHPGGDTV | 446 | O75083 | |
| PVGDHLTYSNETEPV | 471 | Q8NE31 | |
| TTLSVPHPEVDAYEG | 196 | Q9BZV3 | |
| GAEDVYGGSRDTPPH | 421 | P20265 | |
| DEPIPGVGTYDDFHT | 76 | P51790 | |
| TPYEPEEDGATAEGE | 166 | Q7M4L6 | |
| SIHETGPDTIQEPDY | 306 | Q86XK7 | |
| PPGYLSEDGETSDHQ | 181 | P84022 | |
| DTTDEGPVYCVPHEE | 556 | Q96GP6 | |
| PSVEGEHGTEYDTLP | 11 | Q9Y5U2 | |
| TAHGDDVDFPIGYPS | 141 | Q8TEA7 | |
| EEPSHVTGREGFPTD | 116 | P17098 | |
| LGPHVTTEYVGPSSE | 246 | P35442 | |
| FGSGDDPYSSAEPHV | 451 | Q13263 | |
| PEFYTPDDGGTAHLS | 371 | P19440 |